The Biden administration has chosen to prolong tariff exclusions for numerous Chinese products just days before their expiration date on December 31.
The Office of the U.S. Trade Representative stated in a December 26 announcement that this extension would allow for a systematic review of the exclusions, in line with statutory considerations and objectives. The objective is to determine situations where additional time could facilitate shifts in sourcing to the United States or third countries.
This extension applies to 429 products and is scheduled to last until May 31, with the comment period set to open on January 22 and close on February 21.
Both the Trump and Biden administrations have granted exemptions to specific products from the Section 301 tariffs that were imposed on Chinese imports starting in 2018. These exclusions have been renewed several times as the tariffs persisted under both administrations.
Among the items benefiting from exclusion extensions are 77 medical products that have been exempt from tariffs since 2020 due to COVID-19-related concerns, as noted in a Federal Register Notice from the USTR.
The decision to solicit comments on the extensions came after the Biden administration received public input related to the USTR’s ongoing “four-year review” of the Section 301 tariffs initiated in May 2022. The initial phase of this review sought input from domestic industries that had benefited from the tariffs.
When extending the exclusions in December, the USTR also mentioned that these extensions would help align further decisions regarding exclusions with the ongoing four-year review.
This approach has raised questions within the industry. In a public statement, Steve Lamar, President and CEO of the American Apparel & Footwear Association (AAFA), questioned why the administration had initiated a new comment process on these exclusions and why it had yet to announce the results of the overdue four-year review, which already encompassed the existing exclusions.
Lamar also expressed concerns about the timing of the extension, stating, “We are pleased to see the Biden Administration renew the previously approved exclusions, although it is extremely frustrating that it has once again waited until the eleventh hour to extend them.”
Many industry groups, including the AAFA, which rely on imports from China, have opposed these tariffs from their inception during the Trump administration.
According to a 2023 study by major industry organizations, these tariffs added hundreds of millions of dollars in annual costs to apparel, footwear, and travel products, disproportionately impacting lower-income consumers. A study by the U.S. International Trade Commission, also released last year, found that while the tariffs boosted domestic production in specific sectors, downstream industries reliant on imports were negatively affected.
In his recent statement, Lamar emphasized the need to seek ways to reduce tariff burdens during a time of persistent inflation, as these burdens often translate into higher prices for consumers, rather than merely delaying relief.
Stay current with supply chain news on The Supply Chain Report. Free trade resources are available at ADAMftd.com.
#TariffExclusions #BidenAdministration #USTradeRepresentative #ChinaImports #Section301 #MedicalProducts #AAFA #TariffRelief #TradePolicy #SupplyChain #ImportCosts #ConsumerImpact #InflationConcerns
